Lucinda Warren's most recent trade in Cue Biopharma Inc was a trade of 250,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Lucinda Warren | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Lucinda Warren | CHIEF BUSINESS OFFICER | 03 Sep 2024 | 350,000 | 350,000 | - | - | Stock Option (right to buy) |